Showing results (541-550 of 1,030) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|May 1, 2025
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validationAitana Alonso-González, David Jáspez, José M Lorenzo-Salazar, et al.
The Lancet. Respiratory Medicine|June 9, 2025
Efficacy and safety of onradivir in adults with acute uncomplicated influenza A infection in China: a multicentre, double-blind, randomised, placebo-controlled and oseltamivir-controlled, phase 3 trialZifeng Yang, Yangqing Zhan, Zhengtu Li, et al.
The Lancet. Respiratory Medicine|May 23, 2025
Sepsis in patients who are immunocompromised: diagnostic challenges and future therapiesStefanie Deinhardt-Emmer, Benjamin G Chousterman, Joerg C Schefold, et al.
The Lancet. Respiratory Medicine|January 31, 2026
Prognostic factors associated with mortality in septic shock: a systematic review and meta-analysisRichard G Jung, Arnav Gupta, Cameron Stotts, et al.
The Lancet. Respiratory Medicine|March 24, 2025
Preoxygenation strategies for intubation of patients who are critically ill: a systematic review and network meta-analysis of randomised trialsTyler Pitre, Winnie Liu, Dena Zeraatkar, et al.
The Lancet. Respiratory Medicine|October 17, 2017
Palliative care in interstitial lung disease: living wellMichael Kreuter, Elisabeth Bendstrup, Anne-Marie Russell, et al.
The Lancet. Respiratory Medicine|October 8, 2017
Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant dataDavid A Jolliffe, Lauren Greenberg, Richard L Hooper, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trialAdam Penn-Nicholson, Michele Tameris, Erica Smit, et al.
The Lancet. Respiratory Medicine|March 30, 2018
The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB eraKatherine Floyd, Philippe Glaziou, Alimuddin Zumla, et al.
The Lancet. Respiratory Medicine|January 12, 2019
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trialFlorian von Groote-Bidlingmaier, Ramonde Patientia, Epifanio Sanchez, et al.
Pageof 103